0.63
+0.2152(+51.87%)
Currency In USD
| Previous Close | 0.41 |
| Open | 0.44 |
| Day High | 0.65 |
| Day Low | 0.41 |
| 52-Week High | 1.8 |
| 52-Week Low | 0.31 |
| Volume | 26.51M |
| Average Volume | 1.56M |
| Market Cap | 20.48M |
| PE | -0.73 |
| EPS | -0.86 |
| Moving Average 50 Days | 0.55 |
| Moving Average 200 Days | 1.01 |
| Change | 0.22 |
If you invested $1000 in Femasys Inc. (FEMY) since IPO date, it would be worth $52.51 as of October 05, 2025 at a share price of $0.63. Whereas If you bought $1000 worth of Femasys Inc. (FEMY) shares 3 years ago, it would be worth $547.91 as of October 05, 2025 at a share price of $0.63.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
GlobeNewswire Inc.
Sep 25, 2025 1:00 PM GMT
-- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access --ATLANTA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FE
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
GlobeNewswire Inc.
Sep 22, 2025 1:00 PM GMT
Addition strengthens FemSperm family of products and enables gynecologists to offer complete in-office sperm handling for FemaSeed Intratubal InseminationATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
GlobeNewswire Inc.
Sep 11, 2025 1:00 PM GMT
-- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth --ATLANTA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a lead